» Download Public Reports
48 reports
- Company report
- March 2012
- 6 pages
... At the earliest. R&d results look to materialize steadily over the mid/long term, including: 1) the approval of the company S slow-release human growth hormone (for adults) by the us fda and license contracts and 2 ...
March 2012
... Royalty contributions from human papillomavirus vaccines. Australian operations reorganised the integration of the australian plasma operations with csl behring previously announced is now complete ...
March 2012
... Subject to a financing or partnership. Its previous phase i/ii trial of ifn -Kinoid showed encouraging signs of activity and since then, roche has indicated plans to advance its monoclonal antibody ...
March 2012
... Gen S interest in hefei-scigen-bioton biopharmaceutical company ltd the board of directors of scigen limited (asx: sie) (the Scigen ) Announced today that it has closed the transaction on the sale of sci ...
March 2012
... Gen S interest in hefei-scigen-bioton biopharmaceutical company ltd the board of directors of scigen limited (asx: sie) (the Scigen ) Announced today that it has closed the transaction on the sale of sci ...
June 2012
... Such as rhuman growth hormone, rhuman insulin and gcsf. ______________________________________________________________________ Scigen limited arbn 101 318 852 suite 1, 13b narabang way, belrose, nsw 2085 ...
June 2012
... Of gastroenterology, endocrinology and immunology. Its product portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. Scigen has acquired the rights to manufacture, distribute ...
April 2012
... An interspecific nicotiana hybrid as a useful and cost- effective platform for production of animal vaccines huai-yian ling1, aaron m. Edwards1, michael p. Gantier2, kathleen d. Deboer3, alan d ...
March 2012
... Including dairy companies, dairy industry associations, dairy industry supply companies, and government bodies. Recent examples include: Soy versus dairy protein A review of health and physico ...